Enhancing Career Paths for Tomorrow's Radiation Oncologists

Neha Vapiwala; Charles R. Thomas; Surbhi Grover; Mei Ling Yap; T. Mitin; Lawrence N. Shulman; Mary K. Gospodarowicz; John Longo; Daniel G. Petereit; Ronald D. Ennis; James A. Hayman; Danielle Rodin; Jeffrey C. Buchsbaum; Bhadrasain Vikram; May Abdel-Wahab; Alan H. Epstein; Paul Okunieff; Joel Goldwein; Patrick Kupelian; Joanne B. Weidhaas; Margaret A. Tucker; John D. Boice; Clifton David Fuller; Reid F. Thompson; Andrew D. Trister; Silvia C. Formenti; Mary Helen Barcellos-Hoff; Joshua Jones; Kavita V. Dharmarajan; Anthony L. Zietman; C. Norman Coleman

doi:10.1016/j.ijrobp.2019.05.025

Enhancing Career Paths for Tomorrow's Radiation Oncologists

Neha Vapiwala
, Charles R. Thomas
, Surbhi Grover
, Mei Ling Yap
, T. Mitin
, Lawrence N. Shulman
, Mary K. Gospodarowicz
, John Longo
, Daniel G. Petereit
, Ronald D. Ennis
, James A. Hayman
, Danielle Rodin
, Jeffrey C. Buchsbaum
, Bhadrasain Vikram
, May Abdel-Wahab
, Alan H. Epstein
, Paul Okunieff
, Joel Goldwein
, Patrick Kupelian
, Joanne B. Weidhaas

Margaret A. Tucker, John D. Boice, Clifton David Fuller, Reid F. Thompson, Andrew D. Trister, Silvia C. Formenti, Mary Helen Barcellos-Hoff, Joshua Jones, Kavita V. Dharmarajan, Anthony L. Zietman, C. Norman Coleman

Research output: Contribution to journal › Review article › peer-review

22 Scopus citations

Original language	English
Pages (from-to)	52-63
Number of pages	12
Journal	International Journal of Radiation Oncology Biology Physics
Volume	105
Issue number	1
DOIs	https://doi.org/10.1016/j.ijrobp.2019.05.025
State	Published - 1 Sep 2019

Access to Document

10.1016/j.ijrobp.2019.05.025

Cite this

Vapiwala, N., Thomas, C. R., Grover, S., Yap, M. L., Mitin, T., Shulman, L. N., Gospodarowicz, M. K., Longo, J., Petereit, D. G., Ennis, R. D., Hayman, J. A., Rodin, D., Buchsbaum, J. C., Vikram, B., Abdel-Wahab, M., Epstein, A. H., Okunieff, P., Goldwein, J., Kupelian, P., ... Coleman, C. N. (2019). Enhancing Career Paths for Tomorrow's Radiation Oncologists. International Journal of Radiation Oncology Biology Physics, 105(1), 52-63. https://doi.org/10.1016/j.ijrobp.2019.05.025

@article{07779d18e7e44b519a2053bc236b537b,

title = "Enhancing Career Paths for Tomorrow's Radiation Oncologists",

author = "Neha Vapiwala and Thomas, \{Charles R.\} and Surbhi Grover and Yap, \{Mei Ling\} and T. Mitin and Shulman, \{Lawrence N.\} and Gospodarowicz, \{Mary K.\} and John Longo and Petereit, \{Daniel G.\} and Ennis, \{Ronald D.\} and Hayman, \{James A.\} and Danielle Rodin and Buchsbaum, \{Jeffrey C.\} and Bhadrasain Vikram and May Abdel-Wahab and Epstein, \{Alan H.\} and Paul Okunieff and Joel Goldwein and Patrick Kupelian and Weidhaas, \{Joanne B.\} and Tucker, \{Margaret A.\} and Boice, \{John D.\} and Fuller, \{Clifton David\} and Thompson, \{Reid F.\} and Trister, \{Andrew D.\} and Formenti, \{Silvia C.\} and Barcellos-Hoff, \{Mary Helen\} and Joshua Jones and Dharmarajan, \{Kavita V.\} and Zietman, \{Anthony L.\} and Coleman, \{C. Norman\}",

note = "Funding Information: Disclosures: N.V. has received speaker honoraria from Varian Medical Systems. J.G. is a full-time employee of Elekta AB. P.K. is an employee of Varian Medical Systems. J.B.W. reports other from MiraDx, outside the submitted work, and a patent KRAS-variant in cancer with royalties paid to MiraDx. C.D.F. has received industry-funded institutional grant support, speaker honoraria, and travel funding from Elekta AB. P.O. is an inventor and founder of a company that markets biomarker technologies, DiaCarta.com. S.C.F. reports grant/research support from Bristol Myers Squibb, Varian, Janssen, Regeneron, Eisai, Merck, Celldex and honoraria form Bristol Myers Squibb, Varian, Elekta, Janssen, Regeneron, GlaxoSmithKline, Eisai, Dynavax, AstraZeneca, Merck, Viewray, Bayer. T.M. reports personal fees from UpToDate, Inc and Janssen and grants from Novocure, Inc. The remaining authors do not report any relevant conflicts of interest regarding the sections which they co-authored. Funding Information: Drs Vapiwala, Thomas, and Coleman would like to acknowledge Alicia Livinski, National Institutes of Health Library, for her meticulous assistance in the preparation of this manuscript. Disclosures: N.V. has received speaker honoraria from Varian Medical Systems. J.G. is a full-time employee of Elekta AB. P.K. is an employee of Varian Medical Systems. J.B.W. reports other from MiraDx, outside the submitted work, and a patent KRAS-variant in cancer with royalties paid to MiraDx. C.D.F. has received industry-funded institutional grant support, speaker honoraria, and travel funding from Elekta AB. P.O. is an inventor and founder of a company that markets biomarker technologies, DiaCarta.com. S.C.F. reports grant/research support from Bristol Myers Squibb, Varian, Janssen, Regeneron, Eisai, Merck, Celldex and honoraria form Bristol Myers Squibb, Varian, Elekta, Janssen, Regeneron, GlaxoSmithKline, Eisai, Dynavax, AstraZeneca, Merck, Viewray, Bayer. T.M. reports personal fees from UpToDate, Inc and Janssen and grants from Novocure, Inc. The remaining authors do not report any relevant conflicts of interest regarding the sections which they co-authored.",

year = "2019",

month = sep,

day = "1",

doi = "10.1016/j.ijrobp.2019.05.025",

language = "English",

volume = "105",

pages = "52--63",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

number = "1",

}

Vapiwala, N, Thomas, CR, Grover, S, Yap, ML, Mitin, T, Shulman, LN, Gospodarowicz, MK, Longo, J, Petereit, DG, Ennis, RD, Hayman, JA, Rodin, D, Buchsbaum, JC, Vikram, B, Abdel-Wahab, M, Epstein, AH, Okunieff, P, Goldwein, J, Kupelian, P, Weidhaas, JB, Tucker, MA, Boice, JD, Fuller, CD, Thompson, RF, Trister, AD, Formenti, SC, Barcellos-Hoff, MH, Jones, J, Dharmarajan, KV, Zietman, AL & Coleman, CN 2019, 'Enhancing Career Paths for Tomorrow's Radiation Oncologists', International Journal of Radiation Oncology Biology Physics, vol. 105, no. 1, pp. 52-63. https://doi.org/10.1016/j.ijrobp.2019.05.025

TY - JOUR

T1 - Enhancing Career Paths for Tomorrow's Radiation Oncologists

AU - Vapiwala, Neha

AU - Thomas, Charles R.

AU - Grover, Surbhi

AU - Yap, Mei Ling

AU - Mitin, T.

AU - Shulman, Lawrence N.

AU - Gospodarowicz, Mary K.

AU - Longo, John

AU - Petereit, Daniel G.

AU - Ennis, Ronald D.

AU - Hayman, James A.

AU - Rodin, Danielle

AU - Buchsbaum, Jeffrey C.

AU - Vikram, Bhadrasain

AU - Abdel-Wahab, May

AU - Epstein, Alan H.

AU - Okunieff, Paul

AU - Goldwein, Joel

AU - Kupelian, Patrick

AU - Weidhaas, Joanne B.

AU - Tucker, Margaret A.

AU - Boice, John D.

AU - Fuller, Clifton David

AU - Thompson, Reid F.

AU - Trister, Andrew D.

AU - Formenti, Silvia C.

AU - Barcellos-Hoff, Mary Helen

AU - Jones, Joshua

AU - Dharmarajan, Kavita V.

AU - Zietman, Anthony L.

AU - Coleman, C. Norman

N1 - Funding Information: Disclosures: N.V. has received speaker honoraria from Varian Medical Systems. J.G. is a full-time employee of Elekta AB. P.K. is an employee of Varian Medical Systems. J.B.W. reports other from MiraDx, outside the submitted work, and a patent KRAS-variant in cancer with royalties paid to MiraDx. C.D.F. has received industry-funded institutional grant support, speaker honoraria, and travel funding from Elekta AB. P.O. is an inventor and founder of a company that markets biomarker technologies, DiaCarta.com. S.C.F. reports grant/research support from Bristol Myers Squibb, Varian, Janssen, Regeneron, Eisai, Merck, Celldex and honoraria form Bristol Myers Squibb, Varian, Elekta, Janssen, Regeneron, GlaxoSmithKline, Eisai, Dynavax, AstraZeneca, Merck, Viewray, Bayer. T.M. reports personal fees from UpToDate, Inc and Janssen and grants from Novocure, Inc. The remaining authors do not report any relevant conflicts of interest regarding the sections which they co-authored. Funding Information: Drs Vapiwala, Thomas, and Coleman would like to acknowledge Alicia Livinski, National Institutes of Health Library, for her meticulous assistance in the preparation of this manuscript. Disclosures: N.V. has received speaker honoraria from Varian Medical Systems. J.G. is a full-time employee of Elekta AB. P.K. is an employee of Varian Medical Systems. J.B.W. reports other from MiraDx, outside the submitted work, and a patent KRAS-variant in cancer with royalties paid to MiraDx. C.D.F. has received industry-funded institutional grant support, speaker honoraria, and travel funding from Elekta AB. P.O. is an inventor and founder of a company that markets biomarker technologies, DiaCarta.com. S.C.F. reports grant/research support from Bristol Myers Squibb, Varian, Janssen, Regeneron, Eisai, Merck, Celldex and honoraria form Bristol Myers Squibb, Varian, Elekta, Janssen, Regeneron, GlaxoSmithKline, Eisai, Dynavax, AstraZeneca, Merck, Viewray, Bayer. T.M. reports personal fees from UpToDate, Inc and Janssen and grants from Novocure, Inc. The remaining authors do not report any relevant conflicts of interest regarding the sections which they co-authored.

PY - 2019/9/1

Y1 - 2019/9/1

UR - https://www.scopus.com/pages/publications/85070195866

U2 - 10.1016/j.ijrobp.2019.05.025

DO - 10.1016/j.ijrobp.2019.05.025

M3 - Review article

C2 - 31128144

AN - SCOPUS:85070195866

SN - 0360-3016

VL - 105

SP - 52

EP - 63

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 1

ER -